Podcast


Presenter: Dr. Michael Allan James McCormack BSc(Pharm) PharmD Samantha Moe PharmD

In episode 593, Mike and James invite Samantha Moe back to talk about a newer agent for osteoporosis. So, if you want to know all the evidence for romosozumab, tune in and all will be revealed about the benefits and harms. Show notes 1) Tools for Practice Tony Romo-sozumab: Winning touchdown in osteoporosis or interception…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here



CFPCLearn Logo

Listening to the Podcast can earn you MainPro+ Credits

Join Now

Already a CFPCLearn Member? Log in



Latest Podcasts

In the Clinic Episode 58: Neck Pain

In this episode of In the Clinic, the team discusses John Painica, a 52-year-old man presenting with neck pain.
Listen 0.5 credits available

In the Clinic Episode 57: Fibromyalgia

In this episode of In the Clinic, the team discusses Nadia Hench, a 49-year-old woman following up regarding achiness, fatigue, and poor sleep.
Listen 0.5 credits available

BS Medicine Episode #619: Scan, See, Decide: POCUS in the Evaluation of Dyspnea

In episode 619, Mike K and James chat yet again with Émélie Braschi. The topic this time is the use of point-of-care ultrasound (POCUS) to help diagnose patients coming into…
Listen 0.5 credits available

Presenter(s):

Dr. Michael Allan James McCormack BSc(Pharm) PharmD Samantha Moe PharmD

This content is certified for MainPro+ Credits, log in to access


Presenter(s):

  • Dr. Michael Allan
  • James McCormack BSc(Pharm) PharmD
  • Samantha Moe PharmD

Speakers do not have any conflicts of interest to declare.